Dorian Therapeutics Company
FIGHTING AGING. We block senescence at the cellular level to improve medical conditions
Technology:
Geroscience
Industry:
Others
Headquarters:
United States
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
1
Estimated Revenue:
Less than $1M
Last Funding Type:
Seed
Register and Claim Ownership